Redmile Group, LLC Portfolio Holdings

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

Redmile Group, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.53 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $147M, Nurix Therapeutics, Inc. with a value of $96.1M, Amicus Therapeutics, Inc. with a value of $88.1M, Immunome Inc. with a value of $71.5M, and Kymera Therapeutics, Inc. with a value of $65.9M.

Examining the 13F form we can see an decrease of $4.32M in the current position value, from $1.53B to 1.53B.

Redmile Group, LLC is based out at San Francisco, CA

Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.53 Billion
Healthcare: $1.52 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.92B
$147 Million 9.63% of portfolio
810,245
Q3 2024 Reduced 20.65%
$860M
$96.1 Million 6.28% of portfolio
4,280,981
Q3 2024 Reduced 3.22%
$2.53B
$88.1 Million 5.76% of portfolio
8,246,592
Q3 2024 Reduced 22.17%
$127M
$71.5 Million 4.67% of portfolio
4,889,554
Q1 2024 Added 26.04%
$2.09B
$65.9 Million 4.31% of portfolio
1,393,256
Q3 2024 Reduced 11.78%
$355M
$57.9 Million 3.79% of portfolio
4,713,509
Q3 2024 Reduced 0.16%
$545M
$52.4 Million 3.43% of portfolio
4,781,183
Q3 2024 Reduced 14.04%
$325M
$51.3 Million 3.36% of portfolio
4,892,902
Q3 2024 Added 7.07%
$60.5M
$50.8 Million 3.32% of portfolio
3,072,478
Q1 2024 Added 3.4%
$146M
$49.4 Million 3.23% of portfolio
15,669,217
Q3 2024 Added 2.62%
$516M
$48.4 Million 3.17% of portfolio
4,484,380
Q3 2024 Reduced 6.57%
$143M
$46.1 Million 3.01% of portfolio
13,169,057
Q4 2023 Added 0.34%
$2.5B
$45.9 Million 3.0% of portfolio
875,039
Q3 2024 Reduced 5.86%
$2.09B
$42 Million 2.74% of portfolio
5,238,837
Q3 2024 Reduced 3.93%
$1.15B
$39.8 Million 2.6% of portfolio
1,387,479
Q3 2024 Reduced 14.06%
$1.86B
$39.5 Million 2.58% of portfolio
1,611,013
Q3 2024 Reduced 5.4%
$230M
$38.1 Million 2.49% of portfolio
6,427,462
Q2 2024 Added 16.8%
$11.4B
$36.1 Million 2.36% of portfolio
595,570
Q2 2024 Reduced 5.83%
$585M
$35.8 Million 2.34% of portfolio
3,197,491
Q3 2024 Reduced 0.38%
$215M
$34.5 Million 2.26% of portfolio
1,899,317
Q3 2024 Reduced 5.71%
$375M
$32.1 Million 2.1% of portfolio
552,506
Q1 2024 New
$266M
$31.5 Million 2.06% of portfolio
8,253,316
Q1 2024 Added 2.77%
$136B
$27.7 Million 1.81% of portfolio
330,873
Q3 2024 Reduced 15.22%
$1.14B
$22.3 Million 1.46% of portfolio
657,175
Q3 2024 Reduced 8.56%
$1.16B
$21.6 Million 1.41% of portfolio
681,150
Q3 2024 Reduced 10.32%
$50.4M
$19.6 Million 1.28% of portfolio
5,615,489
Q1 2024 Reduced 0.08%
$29.8B
$18.3 Million 1.2% of portfolio
154,456
Q3 2024 New
$3.55B
$17.7 Million 1.16% of portfolio
642,229
Q3 2024 Reduced 10.82%
$179M
$13.6 Million 0.89% of portfolio
1,262,090
Q3 2024 Added 17.57%
$193B
$13.1 Million 0.86% of portfolio
26,698
Q3 2024 Reduced 32.99%
$138B
$11.8 Million 0.77% of portfolio
32,741
Q3 2024 Reduced 17.08%
$320M
$11.6 Million 0.76% of portfolio
1,569,850
Q3 2024 Reduced 10.07%
$801M
$11.4 Million 0.75% of portfolio
1,660,763
Q3 2024 Reduced 11.73%
$1.11B
$11.3 Million 0.74% of portfolio
261,803
Q3 2024 Added 22.9%
$505M
$10.1 Million 0.66% of portfolio
3,065,714
Q2 2024 Added 112.79%
$281M
$8.03 Million 0.52% of portfolio
2,074,350
Q1 2024 Added 56.63%
$72.1M
$6.98 Million 0.46% of portfolio
3,836,576
Q3 2024 Reduced 4.95%
$604M
$6.97 Million 0.46% of portfolio
3,031,009
Q3 2022 Reduced 12.69%
$331M
$6.7 Million 0.44% of portfolio
1,383,366
Q3 2024 Reduced 5.47%
$57.9M
$6.68 Million 0.44% of portfolio
1,942,555
Q2 2024 Reduced 3.66%
$227M
$6.4 Million 0.42% of portfolio
1,694,167
Q3 2024 Reduced 6.28%
$4.39B
$5.13 Million 0.34% of portfolio
97,116
Q3 2024 Reduced 13.19%
$118M
$4.59 Million 0.3% of portfolio
2,107,215
Q3 2024 Reduced 2.63%
$158M
$4.3 Million 0.28% of portfolio
2,108,219
Q2 2024 Reduced 36.28%
$25.3M
$3.44 Million 0.23% of portfolio
2,074,372
Q1 2023 Reduced 26.34%
$118M
$3.42 Million 0.22% of portfolio
310,884
Q3 2024 New
$462M
$2.98 Million 0.19% of portfolio
1,046,587
Q4 2021 New
$2.19M
$2.85 Million 0.19% of portfolio
4,920,178
Q3 2024 Reduced 3.67%
$9.5B
$2.69 Million 0.18% of portfolio
13,847
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.53 Billion
  • Prior Value $1.53 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 32 stocks
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email